Nuzenio

Psoriatic Arthritis Trial

Psoriatic Arthritis Trial news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 5 latest news signals 6 publisher sources 100/100 entity strength

Latest news

MoonLake’s nanobody boosts all clinical endpoints in phase 3 psoriatic arthritis trial - Fierce BiotechFierce Biotech · Mon, 10 Aug 2026 15:00:26 GMTSonelokimab Meets Primary End Point in Phase 3 Psoriatic Arthritis Trial - Dermatology TimesDermatology Times · Mon, 10 Aug 2026 14:00:21 GMTMoonLake Immunotherapeutics Announces Q2 2026 Financial Results and Positive Phase 3 IZAR-1 Trial Data for Sonelokimab in Psoriatic Arthritis - Kalkine MediaKalkine Media · Mon, 10 Aug 2026 13:59:55 GMTMoonLake’s Psoriatic Arthritis Drug Shows Promise In Phase 3 Trial – Retail Shrugs Off Premarket Slide, Says ‘Pipeline Is Intact’ - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 13:24:29 GMTMoonLake Announces Positive Topline Results from the Phase 3 IZAR-1 Trial of Sonelokimab in Psoriatic Arthritis Demonstrating Significant Improvements Across all Clinical Endpoints, and Reports Second Quarter 2026 Financial Results - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 11:19:23 GMTReview examines investigational IL-17A antagonists for psoriatic arthritis - Vera HealthVera Health · Thu, 06 Aug 2026 01:47:58 GMT

Timeline

Mon, 10 Aug 2026 15:00:26 GMTMoonLake’s nanobody boosts all clinical endpoints in phase 3 psoriatic arthritis trial - Fierce Biotech
Mon, 10 Aug 2026 14:00:21 GMTSonelokimab Meets Primary End Point in Phase 3 Psoriatic Arthritis Trial - Dermatology Times
Mon, 10 Aug 2026 13:59:55 GMTMoonLake Immunotherapeutics Announces Q2 2026 Financial Results and Positive Phase 3 IZAR-1 Trial Data for Sonelokimab in Psoriatic Arthritis - Kalkine Media
Mon, 10 Aug 2026 13:24:29 GMTMoonLake’s Psoriatic Arthritis Drug Shows Promise In Phase 3 Trial – Retail Shrugs Off Premarket Slide, Says ‘Pipeline Is Intact’ - Yahoo Finance
Mon, 10 Aug 2026 11:19:23 GMTMoonLake Announces Positive Topline Results from the Phase 3 IZAR-1 Trial of Sonelokimab in Psoriatic Arthritis Demonstrating Significant Improvements Across all Clinical Endpoints, and Reports Second Quarter 2026 Financial Results - The Manila Times
Thu, 06 Aug 2026 01:47:58 GMTReview examines investigational IL-17A antagonists for psoriatic arthritis - Vera Health

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Psoriatic Arthritis Trial.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.